Clinical trial Recruiting at 2 sites Phase1; Phase2 Interventional Ages 18 and up

Comparing complication rates in cataract surgery with different pre-operative treatments

Official title: Prospective Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative Standard of Care

Run by The Eye Centers of Racine and Kenosha · NCT06681688 · Data updated 2026-11-12

This study tests if a new combination of eye treatments before cataract surgery can lower the risk of complications compared to standard care.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment94 (estimated)
SponsorThe Eye Centers of Racine and Kenosha
Academic / other
Locations2 sites (Venice, Florida and 1 other locations)
StatusRecruiting
StartedJuly 10, 2024
Main results expectedJune 2025
Study endsAugust 2025
Registry record updatedNovember 29, 2024
Trial IDNCT06681688 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are undergoing bilateral cataract surgery and are at higher risk for postoperative complications.

Probably not a fit

Patients undergoing cataract surgery combined with other procedures or those with glaucoma may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized study evaluates the complication rates in patients undergoing bilateral cataract extraction. Participants will have one eye treated with a combination of pre-operative NSAIDs, OMIDRIA, and subconjunctival triamcinolone acetonide, while the fellow eye will receive standard of care treatments. The study aims to assess the effectiveness of the new treatment regimen compared to traditional methods in reducing postoperative complications. Patients will be monitored throughout the study for adherence to treatment and outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved postoperative outcomes and reduced complication rates for cataract surgery patients.

How similar studies have gone: Other studies have shown promising results with similar approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult participants \> 18 years of age undergoing bilateral cataract surgery
* Able to provide written informed consent prior to any study related procedure
* Able and willing, as assessed by the Investigator, to follow study instructions, complete study assessments, comply with the protocol, and attend study visits for the duration of the study
* Patients deemed to be "higher risk" for postoperative complications (e.g., well-controlled diabetes (HbA1c ≤7.0), history of uveitis, history of retinal vein occlusion, history of epiretinal membrane, history of vitreomacular traction, evidence of posterior synechiae, etc.) MAY be enrolled provided there has been no evidence of active disease or treatment in the prior 12 months
* Participants who do not meet the exclusion criteria may be enrolled.

Exclusion Criteria:

* Cataract surgery combined with any other procedure (e.g., glaucoma, retina, etc.)
* Glaucoma patients or known steroid responders
* Oral anti-inflammatory medications to treat a systemic disease (exceptions to this include 81 mg aspirin, ibuprofen for headache, etc.)
* Intraocular injection within 6 months
* Any prior ocular implant
* Diagnosis of retinal thickening in the study eye within 12 months of enrollment
* Inability to provide informed consent
* Participation in another clinical trial

Where it's running

  • The Eye Associates - Venice
    Venice, Florida, United States
    Recruiting
  • The Eye Centers of Racine & Kenosha
    Racine, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.